文献速递腹部MR

识别HCV感染患者中存在非富血供低信号结节高风险的适宜EOB-MRI候选者

Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection.
PubMed 文献 · Eur Radiol · 2022-02-10

在481例无HCC病史的HCV感染患者中,评估AFP、FIB-4指数和M2BPGi三种血清标志物与EOB-MRI检出的非富血供低信号结节(NHHN)的关系。M2BPGi预测NHHN的准确性高于AFP和FIB-4指数,ROC曲线下面积最高;多因素分析确定男性和高M2BPGi与NHHN存在相关。作者认为M2BPGi可能识别NHHN高风险的HCV患者,这些患者应考虑行EOB-MRI。

要点

  • M2BPGi预测NHHN存在的准确性高于AFP和FIB-4指数,ROC曲线下面积最高。
  • 多因素分析显示男性和高M2BPGi是与NHHN存在相关的因素。
  • 在相似纤维化程度患者中,M2BPGi较高(COI > 3.46)者NHHN检出更普遍。

核心结论

  • M2BPGi是一种血清标志物,可能识别存在NHHN高风险的HCV患者,对这些患者应考虑行EOB-MRI。

研究设计与样本

  • 研究纳入481例HCV感染且无HCC病史并接受EOB-MRI的患者,测量AFP、FIB-4指数和M2BPGi三种血清标志物,分析其与NHHN存在的关联。

关键影像表现/征象

  • EOB-MRI可检出非富血供低信号结节(NHHN),为高可能进展为HCC的癌前结节。
  • NHHN是HCV感染患者获得持续病毒学应答(SVR)后发生HCC的强危险因素。

诊断标准与关键数值

  • M2BPGi预测NHHN存在的ROC曲线下面积高于AFP和FIB-4指数。
  • 在相似纤维化程度患者中,M2BPGi较高(COI > 3.46)者NHHN检出更普遍。

临床应用与阅片要点

  • 作者认为M2BPGi可能识别NHHN高风险的HCV患者,对这些患者应考虑行EOB-MRI。
  • 由于可及性有限、MRI设备可用性有限和高成本,所有HCV感染患者难以均行EOB-MRI检测NHHN。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Non-hypervascular hypointense nodules (NHHNs) depicted by gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging (EOB-MRI) have a high likelihood of progressing to hepatocellular carcinoma (HCC). The presence of NHHNs is a strong risk factor for HCC development in patients with chronic hepatitis C virus (HCV) infection after the achievement of sustained virologic response (SVR). However, it is difficult for all patients with HCV infection to undergo EOB-MRI for NHHN detection. We therefore explored serum markers that potentially indicate the presence of NHHNs.

METHODS: Three serum markers, alpha-fetoprotein (AFP), FIB-4 index, and Wisteria floribunda agglutinin-positive Mac-2 binding protein glycan isomer (M2BPGi), were measured in 481 patients with HCV infection and no history of HCC who underwent EOB-MRI. The associations between these serum marker levels and the presence of NHHNs were investigated.

RESULTS: All three markers were associated with the presence of NHHNs. M2BPGi predicted the presence of NHHNs more accurately than AFP and FBB-4 index; M2BPGi had the highest area under the receiver operating characteristic curve. Multivariate analysis identified male gender and high M2BPGi as factors associated with the presence of NHHNs. When patients were stratified by the degree of liver fibrosis, M2BPGi increased with the progression of fibrosis. In addition, NHHNs were more prevalently detected in patients with higher M2BPGi (COI > 3.46) in patients with similar fibrosis degree.

CONCLUSIONS: M2BPGi is a serum marker that potentially identifies HCV patients with high risk of the presence of NHHNs, for whom EOB-MRI should be considered.

KEY POINTS: • Non-hypervascular hypointense nodule on EOB-DTPA-enhanced MRI is pre-HCC nodule with high likelihood of progressing to HCC, which is a strong predictor for HCC that develops after the eradication of HCV in patients with HCV infection. • It is difficult for all patients with HCV infection to undergo EOB-MRI for NHHN detection due to limited access, limited availability of MRI equipment, and high costs. • Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein glycan isomer (M2BPGi) levels effectively indicate the presence of NHHNs and can be used to identify patients with high risk of their presence, for whom EOB-DTPA-enhanced MRI should be considered.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Toyoda, Yasuda, Shiota, et al. Identification of the suitable candidates for EOB-MRI with the high risk of the presence of non-hypervascular hypointense nodules in patients with HCV infection. Eur Radiol. 2022. PMID: 35142900. doi:10.1007/s00330-022-08570-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。